Blog

Why CRISPR Therapeutics AG Stock Is Rising Today – Madison.com


Madison.com

Why CRISPR Therapeutics AG Stock Is Rising Today
Madison.com
CRISPR Therapeutics AG (NASDAQ: CRSP), a small-cap contender in the red hot gene-editing race, saw its shares rise by more than 19% in early morning trading today on over 10 times the average daily volume. What's behind this eye-popping surge? Taking
Here's What Pushed Crispr Therapeutics AG Up 23.6% in DecemberMotley Fool


CRISPR Therapeutics Announces Pricing of Public Offering of Common SharesGlobeNewswire (press release)
Crispr Therapeutics (CRSP) Stock: Gaining On Offering PriceCNA Finance (press release)
The Ledger Gazette –Nasdaq –Post Analyst
all 72 news articles »

2018-01-05 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.